Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments
{{output}}
A growing body of evidence now proposes that machine learning and deep learning techniques can serve as a vital foundation for the pharmacogenomics of antidepressant treatments in patients with major depressive disorder (MDD). In this review, we focus on the l... ...
